JPRN-UMIN000017679已完成2 期
Phase II study of hypofractionated proton beam therapy for localized prostate cancer - hypofractionated proton therapy for prostate cancer
Proton Medical Research Center, University of Tsukuba0 个研究点目标入组 125 人开始时间: 2015年6月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Severe complications such as heart failure, and liver dysfunction other active malignant tumors history of pelvis irradiation not to allow discontinuing anticoagulant and antiplatelet therapy severe cognitive impairment
研究者
相似试验
已完成
不适用
The phase II study of hypo-fractionated proton beam therapy for mucosal melanoma of the head and neckJPRN-UMIN000001505ational Cancer Center Hospital East Division of Radiation Oncology35
进行中（未招募）
2 期
Hypofractionated Proton Beam Therapy for Localized Prostate CancerStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7NCT01950351M.D. Anderson Cancer Center241
尚未招募
2 期
Hypofractionated Proton Beam Therapy of 51.6Gy(RBE) in 12 fractions (3 weeks) with real-time-image gated spot-scanning system for non-metastatic prostate cancer (T1c-T4N0M0)Prostate cancerJPRN-UMIN000046163Kyoto Prefectural University of Medicine Department of Radiology180
进行中（未招募）
不适用
Phase II study of hypofractionated radio-chemotherapy with gemcitabine plus oxaliplatin for unresectable nonmetastatic locally advanced pancreatic cancer. - IRST 157.01EUCTR2010-020379-22-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
招募中
2 期
Phase II non-randomized study on proton radiotherapy of thymic malignanciescancerThymoma10027655NL-OMON51962Swedish Lung Cancer Study Group10